Navigation Links
Geneticin in Biological Technology

Calcium Flux Assays using the LabChip 3000

...grown in Ham's F12 medium adjusted to contain 1.5 g/L sodium bicarbonate with 100 U/mL penicillin, 0.1 mg/mL streptomycin, 2 mM L-glutamine, 0.1 mg/mL geneticin G418, 1 mM sodium pyruvate, 10 mM HEPES and 10% Fetal Bovine Serum. Cells were maintained at 37 oC and 5% CO 2 and subcultured in monolayer...

Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation

... solution (Invitrogen Life Technologies, cat # 15630-056), FBS: (Fetal Bovine Serum, heat inactivated, Invitrogen Life Technologies, cat # 10099-141), geneticin (G418, Invitrogen Life Technologies, cat # 10131-019). Fluo-3 and Fura-2 reagent preparation ...

Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors

..., and pindolol from RBI chemicals. Hams F-12 media, foetal bovine serum and geneticin 418 were obtained from Gibco BRL. Method CHO cells ex...ce in Hams F-12 media containing 10% foetal bovine serum and 500 μg/ml geneticin 418, harvested and resuspended in stimulation buffer, containing a phosphod...

The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies

... HEK293 cell line expressing EGF receptor HEK Culture medium: MEM (Sigma M2279) containing: 10% (v/v) FBS geneticin G418, 200 µg/ml (Sigma) L-glutamine (Gibco) Non-essential amino acids (Sigma)

Assay medium: MEM, phenol red ...

The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR

...Sigma) containing 10% (v/v) FBS (Sigma), 200 µ g/ml geneticin G418(Sigma), L-glutamine (Gibco), Non-essential amino... containing 10% (v/v) FBS (Sigma), 200 µ g/ml geneticin G418 (Sigma), L-glutamine, penicillin-streptomycin, (Gibco) ...

Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000

...ged β2-adrenergic receptor

Culture medium: MEM (Sigma) 10% (v/v) FBS (Sigma) 200 µg/ml geneticin 418 (Sigma) L-glutamine (Gibco-BRL) Non-essential amino acids (Sigma)

Assay medium: MEM, phenol red free (In...

Rapid hit confirmation and early hERG liability testing using the IonWorks HT system

... Cat. #11965-092) 10% Fetal Bovine Serum (FBS, Irvine Cat. #3000), 1% Penicillin-Streptomycin (Irvine Cat. #9366) and 1% mL geneticin (G418, Gibco Cat. #10131) PatchPlate consumables (Molecular Devices Cat. #9000-0688) Compound plates (IonWorks HT assay): Cost...
Geneticin in Biological Products

GIBCO Geneticin Selective Antibiotic liquid from Invitrogen

Description: Geneticin Selective Antibiotic liquid...
Company:Invitrogen

pPIC9K from Invitrogen

Description:...namycin resistance gene that confers resistance to geneticin Reagent in Pichia. Spontaneous generation of multi...be identified by resistance to increased levels of geneticin Reagent. Pichia transformants are selected on hist...dium and screened for their level of resistance to geneticin Reagent. The ability to grow in high concentration...
Company:Invitrogen
Other Tags
(Date:8/2/2015)... ... August 03, 2015 , ... A new Phase I research study is looking ... is led by Kenneth G. Lucas, M.D. , chief of the division of ... colleagues at Kosair Children’s Hospital and in the UofL Department of ...
(Date:8/2/2015)... ... August 02, 2015 , ... ... the supportive muscles and connective tissues of a woman’s pelvic organs (uterus, ... damage include straining, heavy lifting, obesity, constipation, multiple vaginal deliveries, genetics, smoking, ...
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather ... continuity of care for patients at this natural health care center in Winamac. , ... Mary Heal said. "Heather's role is vital to our approach because we want to ...
(Date:8/1/2015)... ... August 01, 2015 , ... Western University of ... profession” that comprises a growing percentage of U.S. physicians, and reflects the diversity ... one part of the message delivered by John W. Becher, DO, president of ...
(Date:8/1/2015)... ... 01, 2015 , ... The condition where veins are enlarged and gnarled is ... pain and discomfort. Those who spend a lot of time on their feet and ... is doing what it can to create awareness and provide a cure in observance ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION ... new convenient and secure method to make payments.  ... payment methods, introduced with its groundbreaking voice-direct payment ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/7/2015)... , July 7, 2015  Based on ... Frost & Sullivan recognizes Credence ID, LLC with ... Entrepreneurial Company of the Year Award. Credence ID ... aid in its mission of offering enrollment and ... globally. As Credence ID was formed by experts ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
Other Contents